16-21405020-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_130464.3(NPIPB3):c.916G>C(p.Glu306Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_130464.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NPIPB3 | NM_130464.3 | c.916G>C | p.Glu306Gln | missense_variant | Exon 8 of 12 | NP_569731.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NPIPB3 | ENST00000542817.1 | c.268G>C | p.Glu90Gln | missense_variant | Exon 1 of 2 | 5 | ENSP00000444096.1 | |||
NPIPB3 | ENST00000504841.6 | c.916G>C | p.Glu306Gln | missense_variant | Exon 7 of 7 | 1 | ENSP00000446048.1 | |||
ENSG00000290192 | ENST00000703536.1 | n.239+3826C>G | intron_variant | Intron 2 of 2 | ||||||
NPIPB3 | ENST00000419180.6 | c.*153G>C | downstream_gene_variant | 3 | ENSP00000413141.2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 16AN: 25584Hom.: 0 Cov.: 5 FAILED QC
GnomAD3 exomes AF: 0.00151 AC: 83AN: 54808Hom.: 0 AF XY: 0.000951 AC XY: 26AN XY: 27342
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000298 AC: 203AN: 681982Hom.: 2 Cov.: 10 AF XY: 0.000244 AC XY: 89AN XY: 364052
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000625 AC: 16AN: 25594Hom.: 0 Cov.: 5 AF XY: 0.000376 AC XY: 5AN XY: 13288
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.916G>C (p.E306Q) alteration is located in exon 8 (coding exon 7) of the NPIPB3 gene. This alteration results from a G to C substitution at nucleotide position 916, causing the glutamic acid (E) at amino acid position 306 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at